Logo image of TBN

TAMBORAN RESOURCES CORP (TBN) Stock Fundamental Analysis

USA - NYSE:TBN - US87507T1016 - Common Stock

21.94 USD
-0.08 (-0.36%)
Last: 9/18/2025, 8:26:53 PM
Fundamental Rating

1

TBN gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 210 industry peers in the Oil, Gas & Consumable Fuels industry. The financial health of TBN is average, but there are quite some concerns on its profitability. TBN does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year TBN has reported negative net income.
TBN had a negative operating cash flow in the past year.
In the past 5 years TBN always reported negative net income.
TBN had a negative operating cash flow in each of the past 5 years.
TBN Yearly Net Income VS EBIT VS OCF VS FCFTBN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 -20M -40M -60M -80M -100M

1.2 Ratios

TBN's Return On Assets of -9.68% is on the low side compared to the rest of the industry. TBN is outperformed by 83.33% of its industry peers.
Looking at the Return On Equity, with a value of -13.98%, TBN is doing worse than 74.29% of the companies in the same industry.
Industry RankSector Rank
ROA -9.68%
ROE -13.98%
ROIC N/A
ROA(3y)-17.14%
ROA(5y)-37.79%
ROE(3y)-18.68%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
TBN Yearly ROA, ROE, ROICTBN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 0 50 -50 -100 -150

1.3 Margins

TBN does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
TBN Yearly Profit, Operating, Gross MarginsTBN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 -5K -10K

More info and screens

4

2. Health

2.1 Basic Checks

TBN does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for TBN has been increased compared to 1 year ago.
Compared to 5 years ago, TBN has more shares outstanding
The debt/assets ratio for TBN has been reduced compared to a year ago.
TBN Yearly Shares OutstandingTBN Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 500M 1B
TBN Yearly Total Debt VS Total AssetsTBN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M 250M

2.2 Solvency

TBN has an Altman-Z score of 1.95. This is not the best score and indicates that TBN is in the grey zone with still only limited risk for bankruptcy at the moment.
TBN has a Altman-Z score of 1.95. This is in the better half of the industry: TBN outperforms 65.71% of its industry peers.
TBN has a Debt/Equity ratio of 0.05. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.05, TBN is in the better half of the industry, outperforming 79.05% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF N/A
Altman-Z 1.95
ROIC/WACCN/A
WACC8.84%
TBN Yearly LT Debt VS Equity VS FCFTBN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 0 100M -100M 200M

2.3 Liquidity

TBN has a Current Ratio of 1.36. This is a normal value and indicates that TBN is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of TBN (1.36) is better than 63.81% of its industry peers.
TBN has a Quick Ratio of 1.36. This is a normal value and indicates that TBN is financially healthy and should not expect problems in meeting its short term obligations.
TBN has a better Quick ratio (1.36) than 69.05% of its industry peers.
Industry RankSector Rank
Current Ratio 1.36
Quick Ratio 1.36
TBN Yearly Current Assets VS Current LiabilitesTBN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M

More info and screens

0

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 50.18% over the past year.
Looking at the last year, TBN shows a very negative growth in Revenue. The Revenue has decreased by -86.95% in the last year.
EPS 1Y (TTM)50.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50.59%
Revenue 1Y (TTM)-86.95%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

The Earnings Per Share is expected to decrease by -236.77% on average over the next years. This is quite bad
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-8462.39%
EPS Next 2Y-854.63%
EPS Next 3Y-294.46%
EPS Next 5Y-236.77%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
TBN Yearly Revenue VS EstimatesTBN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2026 2027 20M 40M 60M
TBN Yearly EPS VS EstimatesTBN Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 -0.5 -1 -1.5 -2 -2.5

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

TBN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for TBN. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
TBN Price Earnings VS Forward Price EarningsTBN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 -20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
TBN Per share dataTBN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6 8 10

4.3 Compensation for Growth

A cheap valuation may be justified as TBN's earnings are expected to decrease with -294.46% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-854.63%
EPS Next 3Y-294.46%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for TBN!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

TAMBORAN RESOURCES CORP

NYSE:TBN (9/18/2025, 8:26:53 PM)

21.94

-0.08 (-0.36%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)05-14 2025-05-14/bmo
Earnings (Next)09-19 2025-09-19
Inst Owners17.42%
Inst Owner Change43.02%
Ins Owners0.69%
Ins Owner Change10.26%
Market Cap389.87M
Analysts80
Price Target41.21 (87.83%)
Short Float %0.11%
Short Ratio0.89
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-0.49%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 4597.57
P/FCF N/A
P/OCF N/A
P/B 1.98
P/tB 1.98
EV/EBITDA N/A
EPS(TTM)-1.08
EYN/A
EPS(NY)-1.94
Fwd EYN/A
FCF(TTM)-2.35
FCFYN/A
OCF(TTM)-0.4
OCFYN/A
SpS0
BVpS11.08
TBVpS11.08
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -9.68%
ROE -13.98%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-17.14%
ROA(5y)-37.79%
ROE(3y)-18.68%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score1
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 40748.8%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.36
Quick Ratio 1.36
Altman-Z 1.95
F-Score1
WACC8.84%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)50.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50.59%
EPS Next Y-8462.39%
EPS Next 2Y-854.63%
EPS Next 3Y-294.46%
EPS Next 5Y-236.77%
Revenue 1Y (TTM)-86.95%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-3.15%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year50.3%
EBIT Next 3Y16.11%
EBIT Next 5Y19.94%
FCF growth 1Y-3.02%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y26.47%
OCF growth 3YN/A
OCF growth 5YN/A